ImmunoPrecise Antibodies Ltd. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| INGALLS & SNYDER LLC | 01/29/2025 | 1.56 M | $643,000 | 0.16% | 5.55% |
| RENAISSANCE TECHNOLOGIES LLC | 02/13/2025 | 78,200 | $32,195 | 29.68% | 0.28% |
| CIBC WORLD MARKET INC. | 01/23/2025 | 41,200 | $17,000 | 0.00% | 0.15% |
| NORTHERN TRUST CORP | 02/14/2025 | 41,106 | $16,923 | -18.97% | 0.15% |
| BANK OF MONTREAL /CAN/ | 02/13/2025 | 35,307 | $14,536 | -38.92% | 0.13% |
| GRADIENT CAPITAL ADVISORS, LLC | 01/29/2025 | 26,808 | $11,037 | 0.00% | 0.10% |
| FEDERATION DES CAISSES DESJARDINS DU QUEBEC | 02/14/2025 | 26,273 | $10,824 | 0.00% | 0.09% |
| XTX TOPCO LTD | 02/13/2025 | 23,399 | $9,633 | 49.28% | 0.08% |
| VIRTU FINANCIAL LLC | 02/11/2025 | 20,759 | $9,000 | 100.00% | 0.07% |
| RATHBONES GROUP PLC | 02/13/2025 | 14,000 | $5,763 | 0.00% | 0.05% |
| MORGAN STANLEY | 02/14/2025 | 12,533 | $5,160 | 0.00% | 0.04% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/12/2025 | 10,668 | $4,392 | -38.98% | 0.04% |
| MARINER, LLC | 02/13/2025 | 10,000 | $4,117 | 0.00% | 0.04% |
| BANK OF AMERICA CORP /DE/ | 02/14/2025 | 2,000 | $822 | 0.00% | 0.01% |
| NATIONAL BANK OF CANADA /FI/ | 02/12/2025 | 1,671 | $688 | 0.00% | 0.01% |
| WEST PACES ADVISORS INC. | 02/14/2025 | 1,665 | $685 | 0.00% | 0.01% |
| GROUP ONE TRADING, L.P. | 02/14/2025 | 61 | $25 | 0.00% | 0.00% |
| CITIGROUP INC | 02/12/2025 | 7 | $3 | 0.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
ImmunoPrecise Antibodies Ltd. institutional Ownership - FAQ's
During the previous two years, 19 institutional investors and hedge funds held shares of ImmunoPrecise Antibodies Ltd.. The most heavily invested institutionals were:
INGALLS & SNYDER LLC: 1.56 M
RENAISSANCE TECHNOLOGIES LLC: 78,200
CIBC WORLD MARKET INC.: 41,200
NORTHERN TRUST CORP: 41,106
BANK OF MONTREAL /CAN/: 35,307
Gradient Capital Advisors, LLC: 26,808
6.78% of ImmunoPrecise Antibodies Ltd. stock is owned by institutional investors.
Institutional investors have bought a total of 1.93 M shares in the last 24 months. This purchase volume represents approximately $694,639 in transactions.